key: cord-0684751-4bxnm91v
authors: Kadosh, Bernard S.; Pavone, Jennifer; Wu, Ming; Reyentovich, Alex; Gidea, Claudia
title: Collapsing Glomerulopathy Associated with COVID-19 Infection in a Heart Transplant Recipient
date: 2020-06-07
journal: J Heart Lung Transplant
DOI: 10.1016/j.healun.2020.05.013
sha: d8e8df2883a5d6fba0db852a84cba92baff2e0c3
doc_id: 684751
cord_uid: 4bxnm91v

nan

A 56 year-old African American male with ischemic cardiomyopathy and chronic kidney disease who underwent heart transplantation over one year prior to presentation was admitted to our institution with dry cough, myalgias, and diarrhea concerning for COVID-19 infection.

Nasal swab polymerase chain reaction assay was positive for the SARS-CoV-2 virus. Initial labs revealed acute kidney injury (creatinine 1.86 mg/dL). Initial ferritin and interleukin-6 (IL-6) levels were within reference range. D-dimer was elevated at 306 ng/mL and c-reactive protein (CRP) was elevated at 20.5 mg/L. Treatment with hydroxychloroquine and nitazoxanide was initiated.

Azithromycin was deferred due to a prolonged QTc of 517 ms. Immunosuppression with tacrolimus was resumed due multiple episodes of allograft rejection in the past, however mycophenolate and prednisone were stopped. Baseline urine studies had revealed mild nephrotic range proteinuria (1973 mg/dL). Over the course of 7 days his renal dysfunction rapidly progressed (creatinine peak 7.78 mg/dL) with marked elevation in urine protein/creatinine ratio to 7354 mg/dL. Inflammatory markers continued to rise (ferritin 637 ng/mL, IL-6 11 pg/mL, CRP 61.1 mg/L, D-dimer 1562 ng/mL). Percutaneous needle core kidney biopsy showed acute tubular injury as well as collapsed capillary tufts with overlying visceral epithelial cell hyperplasia and protein droplets within Bowman's space, diagnostic of collapsing glomerulopathy (Figure 1 ). Electron microscopy revealed coronavirus particles within the tubular epithelial cells (Figure 2 ). There was no evidence of immune complex mediated or monoclonal associated disease. Antineutrophil cytoplasmic antibodies, anti-double stranded DNA antibodies, HIV, and hepatitis serologies were negative. Chest radiography showed progressive patchy bilateral infiltrates consistent with atypical pneumonia, however the patient remained afebrile with adequate oxygen saturation on room air and did not require respiratory support. His inflammatory markers subsequently down-trended as his renal function improved with supportive care. He did not require dialysis and was eventually discharged home.

Collapsing glomerulopathy has a known association to viral infections including the first SARS-CoV from the outbreak in 2002. 1 To our knowledge, this is the first case of collapsing glomerulopathy associated with COVID-19 infection reported in a heart transplant recipient.

Rare reports of similar cases in non-transplant patients have recently emerged in the literature. 2,3 One case involved a 44 year-old African American female who was homozygous for the G1 risk allele in the APOL1 gene (a known risk factor for collapsing glomerulopathy). 2 In that report, SARS-CoV-2 RNA was detected in the biopsy specimen, but whether the patient's glomerulopathy was triggered by the virus directly or the resulting cytokine storm is unclear. Our patient had baseline proteinuria prior to transplantation and feasibly could have had an undiagnosed focal segmental glomerulosclerosis (FSGS) prior to SARS-CoV-2 infection, however the rapidly progressive nature of his renal dysfunction, and subsequent improvement following resolution of his illness suggests an association.

The incidence of acute kidney injury (AKI) as a complication of COVID-19 has been variably reported. A case series of 116 patients from the initial outbreak in Wuhan, China did not show an association between SARS-CoV-2 infection and AKI. 4 Conversely, AKI has been seen in 5-7% of hospitalized patients and up to 23% of ICU cases in other studies. 5, 6 Moreover, baseline renal dysfunction and AKI were shown to be independent predictors of mortality in a prospective study of 701 patients. 5 Fragments of SARS-CoV-2 RNA have been detected urine sediment, 2,5 however analysis of renal biopsy specimens were not performed in these reports.

Kidney specimens from SARS-CoV in 2002 demonstrated moderate acute tubular injury without glomerular pathology or viral inclusion bodies. 1 Notably, transplant patients were not included in these studies and little information is available to date on the natural history of COVID-19 and its interaction with baseline immunosuppressive regimens in this patient population. 

Acute renal impairment in coronavirus-associated severe acute respiratory syndrome

Collapsing Glomerulopathy in a Patient With Coronavirus Disease 2019 (COVID-19)

Collapsing glomerulopathy in a COVID-19 patient

Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China

Kidney disease is associated with in-hospital death of patients with COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Henry J. Neumann Surya V. Seshan

None